Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Reporting recommendations for tumor marker prognostic studies (remark).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Exp Oncol. 2006 Jun;28(2):99-105.

PMID:
16837898
[PubMed - indexed for MEDLINE]
2.

Reporting recommendations for tumor marker prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4.

PMID:
16106022
[PubMed - indexed for MEDLINE]
Free Article
3.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics.

Breast Cancer Res Treat. 2006 Nov;100(2):229-35. Epub 2006 Aug 24.

PMID:
16932852
[PubMed - indexed for MEDLINE]
4.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Oncol. 2005 Aug;2(8):416-22.

PMID:
16130938
[PubMed - indexed for MEDLINE]
5.

REporting recommendations for tumor MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Nat Clin Pract Urol. 2005 Aug;2(8):416-22.

PMID:
16482653
[PubMed - indexed for MEDLINE]
6.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Eur J Cancer. 2005 Aug;41(12):1690-6.

PMID:
16043346
[PubMed - indexed for MEDLINE]
7.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.

Br J Cancer. 2005 Aug 22;93(4):387-91.

PMID:
16106245
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

PMID:
10545862
[PubMed - as supplied by publisher]
Free Article
9.

Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.

Dundar Y, Dodd S, Dickson R, Walley T, Haycox A, Williamson PR.

Health Technol Assess. 2006 Feb;10(5):iii-iv, ix-145. Review.

PMID:
16487455
[PubMed - indexed for MEDLINE]
Free Article
10.

[Diagnostic (STARD) and prognostic (REMARK) studies].

Altman DG, Bossuyt PM; STARD group; REMARK group.

Med Clin (Barc). 2005 Dec 1;125 Suppl 1:49-55. Spanish.

PMID:
16464428
[PubMed - indexed for MEDLINE]
11.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
13.

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Altman DG, McShane LM, Sauerbrei W, Taube SE.

BMC Med. 2012 May 29;10:51. doi: 10.1186/1741-7015-10-51.

PMID:
22642691
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.

Mallett S, Timmer A, Sauerbrei W, Altman DG.

Br J Cancer. 2010 Jan 5;102(1):173-80. doi: 10.1038/sj.bjc.6605462. Epub 2009 Dec 8. Review.

PMID:
19997101
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
[PubMed - indexed for MEDLINE]
16.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
[PubMed - indexed for MEDLINE]
Free Article
17.

Practice guidelines for tumor marker use in the clinic.

Sturgeon C.

Clin Chem. 2002 Aug;48(8):1151-9. Review.

PMID:
12142367
[PubMed - indexed for MEDLINE]
Free Article
18.

Quality of reporting of test accuracy studies in reproductive medicine: impact of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative.

Coppus SF, van der Veen F, Bossuyt PM, Mol BW.

Fertil Steril. 2006 Nov;86(5):1321-9. Epub 2006 Sep 14.

PMID:
16978620
[PubMed - indexed for MEDLINE]
19.
20.

A critical synopsis of the diagnostic and screening radiology outcomes literature.

Blackmore CC, Black WC, Jarvik JG, Langlotz CP.

Acad Radiol. 1999 Jan;6 Suppl 1:S8-18.

PMID:
9891161
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk